Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 3 | 2023 | 22 | 2.150 |
Why?
|
| Cochlear Implants | 3 | 2023 | 29 | 2.130 |
Why?
|
| Neuroma, Acoustic | 6 | 2022 | 10 | 2.100 |
Why?
|
| Tinnitus | 6 | 2019 | 12 | 1.990 |
Why?
|
| Vestibule, Labyrinth | 3 | 2022 | 7 | 1.770 |
Why?
|
| Otosclerosis | 8 | 2021 | 8 | 1.490 |
Why?
|
| Ear, Middle | 4 | 2019 | 8 | 1.460 |
Why?
|
| Stapes Surgery | 8 | 2021 | 8 | 1.350 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 14 | 1.090 |
Why?
|
| Postoperative Complications | 9 | 2021 | 930 | 1.020 |
Why?
|
| Internship and Residency | 2 | 2018 | 216 | 0.950 |
Why?
|
| Ear Neoplasms | 2 | 2015 | 7 | 0.950 |
Why?
|
| Hydroxyapatites | 3 | 2020 | 9 | 0.910 |
Why?
|
| Neurilemmoma | 2 | 2022 | 14 | 0.910 |
Why?
|
| Otolaryngology | 3 | 2020 | 29 | 0.880 |
Why?
|
| Speech Perception | 1 | 2023 | 55 | 0.830 |
Why?
|
| Otologic Surgical Procedures | 4 | 2017 | 4 | 0.830 |
Why?
|
| Humans | 48 | 2023 | 28054 | 0.830 |
Why?
|
| Retrospective Studies | 23 | 2023 | 3524 | 0.750 |
Why?
|
| Craniotomy | 2 | 2019 | 21 | 0.730 |
Why?
|
| Bone Cements | 2 | 2020 | 91 | 0.710 |
Why?
|
| Endoscopy | 2 | 2018 | 181 | 0.690 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2019 | 1 | 0.660 |
Why?
|
| Dizziness | 1 | 2019 | 18 | 0.650 |
Why?
|
| Temporal Bone | 2 | 2017 | 8 | 0.640 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 21 | 0.620 |
Why?
|
| Ear, Inner | 3 | 2019 | 4 | 0.590 |
Why?
|
| Malleus | 1 | 2017 | 1 | 0.590 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3530 | 0.570 |
Why?
|
| Skull | 1 | 2017 | 23 | 0.560 |
Why?
|
| Stapedius | 1 | 2017 | 1 | 0.560 |
Why?
|
| Incidental Findings | 1 | 2017 | 14 | 0.550 |
Why?
|
| Vascular Malformations | 1 | 2017 | 6 | 0.550 |
Why?
|
| Ear Canal | 2 | 2022 | 4 | 0.540 |
Why?
|
| Cartilage | 1 | 2017 | 104 | 0.540 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 243 | 0.540 |
Why?
|
| Male | 26 | 2021 | 15143 | 0.530 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 99 | 0.520 |
Why?
|
| Middle Aged | 22 | 2021 | 9186 | 0.510 |
Why?
|
| Stroke | 1 | 2019 | 272 | 0.510 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 4 | 0.510 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 56 | 0.500 |
Why?
|
| Microsurgery | 2 | 2015 | 42 | 0.500 |
Why?
|
| Exostoses | 1 | 2015 | 1 | 0.500 |
Why?
|
| Osteoma | 1 | 2015 | 5 | 0.490 |
Why?
|
| Adult | 21 | 2021 | 8021 | 0.490 |
Why?
|
| Microscopy | 1 | 2015 | 10 | 0.480 |
Why?
|
| Lighting | 1 | 2015 | 18 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 758 | 0.470 |
Why?
|
| Meniere Disease | 3 | 2021 | 3 | 0.470 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2014 | 1 | 0.470 |
Why?
|
| Eyeglasses | 1 | 2014 | 3 | 0.470 |
Why?
|
| Eye Movements | 1 | 2014 | 12 | 0.470 |
Why?
|
| Physician's Role | 1 | 2014 | 19 | 0.450 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 120 | 0.430 |
Why?
|
| Adenoma | 1 | 2014 | 60 | 0.430 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2012 | 1 | 0.420 |
Why?
|
| Biomarkers | 1 | 2016 | 581 | 0.420 |
Why?
|
| Eustachian Tube | 2 | 2019 | 4 | 0.410 |
Why?
|
| Female | 25 | 2021 | 15534 | 0.410 |
Why?
|
| Acoustic Impedance Tests | 1 | 2011 | 1 | 0.380 |
Why?
|
| Reoperation | 6 | 2021 | 906 | 0.370 |
Why?
|
| Hearing Loss | 2 | 2021 | 15 | 0.370 |
Why?
|
| Aged | 17 | 2020 | 9222 | 0.370 |
Why?
|
| Hearing Loss, Sudden | 1 | 2010 | 1 | 0.360 |
Why?
|
| Heroin | 1 | 2010 | 2 | 0.360 |
Why?
|
| Hearing Aids | 1 | 2010 | 3 | 0.360 |
Why?
|
| Family Practice | 1 | 2010 | 15 | 0.350 |
Why?
|
| Triage | 1 | 2010 | 21 | 0.350 |
Why?
|
| Cerebellopontine Angle | 2 | 2020 | 4 | 0.340 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 370 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 313 | 0.300 |
Why?
|
| Stapes | 3 | 2021 | 3 | 0.280 |
Why?
|
| Hearing | 3 | 2021 | 21 | 0.270 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 4846 | 0.270 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 52 | 0.260 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 2 | 0.250 |
Why?
|
| Encephalocele | 2 | 2022 | 24 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 1181 | 0.250 |
Why?
|
| Tympanic Membrane | 2 | 2017 | 4 | 0.240 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 3 | 0.240 |
Why?
|
| Adolescent | 7 | 2021 | 2289 | 0.240 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2021 | 3 | 0.240 |
Why?
|
| Endolymphatic Sac | 1 | 2004 | 3 | 0.230 |
Why?
|
| Databases as Topic | 1 | 2023 | 15 | 0.220 |
Why?
|
| Facial Nerve | 3 | 2020 | 13 | 0.210 |
Why?
|
| Cranial Fossa, Middle | 1 | 2022 | 4 | 0.200 |
Why?
|
| Radiosurgery | 2 | 2020 | 38 | 0.200 |
Why?
|
| Cochlea | 1 | 2022 | 3 | 0.200 |
Why?
|
| Mastoidectomy | 1 | 2022 | 1 | 0.200 |
Why?
|
| Ossicular Prosthesis | 2 | 2020 | 2 | 0.200 |
Why?
|
| Mastoid | 3 | 2022 | 3 | 0.190 |
Why?
|
| Ossicular Replacement | 1 | 2020 | 1 | 0.180 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 7 | 0.180 |
Why?
|
| Facial Paralysis | 1 | 2020 | 9 | 0.180 |
Why?
|
| Anesthesia, General | 1 | 2020 | 28 | 0.180 |
Why?
|
| Arteries | 1 | 2020 | 14 | 0.180 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 8 | 0.180 |
Why?
|
| Urban Health Services | 1 | 2020 | 14 | 0.170 |
Why?
|
| Patient Care Team | 2 | 2014 | 142 | 0.170 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 128 | 0.170 |
Why?
|
| Ear Diseases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Brain Abscess | 1 | 2019 | 5 | 0.170 |
Why?
|
| Young Adult | 5 | 2020 | 2043 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 373 | 0.170 |
Why?
|
| Tuberculosis | 1 | 2019 | 20 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 114 | 0.160 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 5 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 77 | 0.160 |
Why?
|
| Quality of Life | 1 | 2004 | 655 | 0.160 |
Why?
|
| Skull Base | 1 | 2019 | 33 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 91 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 95 | 0.150 |
Why?
|
| Telemedicine | 1 | 2020 | 110 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 121 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 207 | 0.150 |
Why?
|
| Sepsis | 1 | 2019 | 142 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 80 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2020 | 434 | 0.140 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2021 | 13 | 0.140 |
Why?
|
| Child | 4 | 2021 | 1407 | 0.140 |
Why?
|
| Risk Factors | 4 | 2021 | 2371 | 0.130 |
Why?
|
| Cadaver | 1 | 2017 | 378 | 0.130 |
Why?
|
| Chemokines | 1 | 2016 | 21 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 206 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 511 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 66 | 0.130 |
Why?
|
| Vestibular Function Tests | 1 | 2015 | 2 | 0.130 |
Why?
|
| Hearing Disorders | 1 | 2015 | 2 | 0.130 |
Why?
|
| Semicircular Canals | 1 | 2015 | 5 | 0.130 |
Why?
|
| Endometrium | 1 | 2015 | 7 | 0.120 |
Why?
|
| Hemifacial Spasm | 1 | 2014 | 1 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2015 | 32 | 0.120 |
Why?
|
| Burns | 1 | 2015 | 26 | 0.120 |
Why?
|
| United States | 2 | 2018 | 2155 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 20 | 0.120 |
Why?
|
| Melanoma | 1 | 2015 | 60 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 79 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 990 | 0.110 |
Why?
|
| HIV Infections | 1 | 2019 | 481 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 145 | 0.110 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 1 | 0.110 |
Why?
|
| Vestibular Nerve | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2013 | 4 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 103 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2014 | 19 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 139 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 441 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2014 | 91 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 130 | 0.110 |
Why?
|
| Gentamicins | 2 | 2002 | 16 | 0.100 |
Why?
|
| Anxiety | 1 | 2014 | 155 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 2 | 2021 | 3 | 0.100 |
Why?
|
| Comorbidity | 1 | 2014 | 497 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 105 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 306 | 0.100 |
Why?
|
| Bone Conduction | 2 | 2021 | 2 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 8 | 0.090 |
Why?
|
| Drug Overdose | 1 | 2010 | 4 | 0.090 |
Why?
|
| Auditory Threshold | 1 | 2010 | 24 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2011 | 118 | 0.090 |
Why?
|
| Respiration | 1 | 2010 | 33 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2010 | 43 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 57 | 0.090 |
Why?
|
| Meditation | 1 | 2010 | 21 | 0.090 |
Why?
|
| Tympanoplasty | 2 | 2017 | 3 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 555 | 0.080 |
Why?
|
| Depression | 1 | 2014 | 452 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 103 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 244 | 0.070 |
Why?
|
| Time Factors | 2 | 2020 | 1485 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1882 | 0.060 |
Why?
|
| Round Window, Ear | 1 | 2002 | 1 | 0.050 |
Why?
|
| Labyrinthine Fluids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 432 | 0.050 |
Why?
|
| Otitis Media | 1 | 2002 | 4 | 0.050 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 715 | 0.050 |
Why?
|
| Contraindications | 1 | 2021 | 33 | 0.050 |
Why?
|
| Granuloma | 1 | 2021 | 15 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2020 | 2 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1690 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 18 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 35 | 0.040 |
Why?
|
| South Africa | 1 | 2019 | 12 | 0.040 |
Why?
|
| Myoclonus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Neuroma | 1 | 2019 | 3 | 0.040 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 4 | 0.040 |
Why?
|
| Meningioma | 1 | 2019 | 13 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 14 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 1201 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 78 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 67 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 257 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 57 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 492 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2017 | 160 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 353 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 132 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 3 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 8 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 26 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 35 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 44 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 23 | 0.030 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 4 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 8 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 79 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 72 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 97 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 286 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 337 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 31 | 0.010 |
Why?
|
| Fascia | 1 | 2002 | 7 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 678 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1748 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 1809 | 0.010 |
Why?
|